FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Res Commun / Plasma concentrations of a type II collagen-derived peptide ...
Veterinary research communications2007; 31(5); 591-601; doi: 10.1007/s11259-007-3518-2

Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy.

Abstract: Several breeds of draft horses suffer from degenerative digital osteoarthropathy, resulting in a reduced active lifespan. A group of 30 Ardenner horses was followed, in standardized conditions, from 15 to 28 months of age to detect the early manifestations of the disease. The severity of the disease was assessed according to a personal grading system including clinical and radiographic items. Coll 2-1, a peptide of the helical region of type II collagen, and its nitrated form (Coll 2-1 NO(2)) were assayed in blood plasma collected at 452 +/- 18 days, 504 +/- 20 days, 558 +/- 18 days, 613 +/- 19 days, 675 +/- 19 days, 752 +/- 21 days and 852 +/- 19 days of age. At the end of the follow-up period, 53.3% of Ardenner horses were affected by a degenerative digital osteoarthropathy. A significant effect (p<0.05) of time, sex and pathology was observed for Coll 2-1 NO(2). Variations of Coll 2-1 were not significant except for the time effect. The elevation of Coll 2-1 NO(2) in the pathological group could indicate an inflammatory process during the growth of the affected horses, as nitration of tyrosine is mediated through reactive oxygen/nitrogen species and/or myeloperoxidase activity. Coll 2-1 NO(2) appears to be an interesting early marker of cartilage degradation and oxidation in degenerative osteoarthropathy.
Get Full Text
Publication Date: 2007-01-24 PubMed ID: 17252318DOI: 10.1007/s11259-007-3518-2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the levels of a certain type of collagen-derived peptide in the blood of Ardenner draft horses. The researchers found that increased levels of this peptide were linked to a type of degenerative bone disease common in this breed.

Overview of the Study

  • The study was carried out on a group of 30 Ardenner horses, aged between 15 to 28 months. The aim was to identify early signs of degenerative digital osteoarthropathy, a disease common in several breeds of draft horses which shortens their active lifespan.
  • The severity of the disease in the horses was measured using a personalized grading system, including clinical and radiographic examinations. Blood plasma was also collected from the horses at specified intervals, to measure levels of Coll 2-1, a type II collagen-derived peptide, and its nitrated form (Coll 2-1 NO(2)).

The Findings

  • By the end of the monitoring period, slightly over half (53.3%) of the horses were found to be affected by the disease.
  • Significant changes in levels of Coll 2-1 NO(2) were observed over time, with differences also noted based on sex and presence of the disease.
  • The only significant variations observed in Coll 2-1 levels were related to the passage of time.

Analysis and Implications

  • The increase in Coll 2-1 NO(2) levels in affected horses suggests that an inflammatory process is occurring during growth. It is postulated that this inflammation could be due to nitration of tyrosine, a process mediated by reactive oxygen/nitrogen species and/or the activity of an enzyme called myeloperoxidase.
  • In light of these findings, Coll 2-1 NO(2) appears to be a potentially useful early marker for cartilage degradation and oxidation in degenerative osteoarthropathy. This could be instrumental in early diagnosis, management, and treatment of this debilitative disease in horses.

Cite This Article

APA
Lejeune JP, Serteyn D, Gangl M, Schneider N, Deby-Dupont G, Deberg M, Henrotin Y. (2007). Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Vet Res Commun, 31(5), 591-601. https://doi.org/10.1007/s11259-007-3518-2

Publication

Veterinary research communications
ISSN: 0165-7380
NlmUniqueID: 8100520
Country: Switzerland
Language: English
Volume: 31
Issue: 5
Pages: 591-601

Researcher Affiliations

Lejeune, J-Ph
  • Centre Européen du Cheval, Mont-le-Soie, Vielsalm, Belgium. jph.lejeune@student.ulg.ac.be
Serteyn, D
    Gangl, M
      Schneider, N
        Deby-Dupont, G
          Deberg, M
            Henrotin, Y

              MeSH Terms

              • Aging
              • Animals
              • Bone Diseases / blood
              • Bone Diseases / pathology
              • Bone Diseases / veterinary
              • Collagen Type II / blood
              • Collagen Type II / chemistry
              • Female
              • Health
              • Horse Diseases / blood
              • Horse Diseases / pathology
              • Horses / blood
              • Horses / growth & development
              • Joint Diseases / blood
              • Joint Diseases / pathology
              • Joint Diseases / veterinary
              • Male
              • Sex Characteristics

              References

              This article includes 31 references
              1. Kettle AJ, van Dalen CJ, Winterbourn CC. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration.. Redox Rep 1997 Oct-Dec;3(5-6):257-8.
                pubmed: 9754322doi: 10.1080/13510002.1997.11747120google scholar: lookup
              2. McIlwraith CW. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review.. Equine Vet J 2005 Sep;37(5):473-82.
                pubmed: 16163952doi: 10.2746/042516405774480102google scholar: lookup
              3. Golden BL, Brinks JS, Bourdon RM. A performance programmed method for computing inbreeding coefficients from large data sets for use in mixed-model analyses.. J Anim Sci 1991 Sep;69(9):3564-73.
                pubmed: 1938642doi: 10.2527/1991.6993564xgoogle scholar: lookup
              4. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.. J Immunol 1991 Dec 1;147(11):3915-20.
                pubmed: 1658153
              5. Chiang K, Parthasarathy S, Santanam N. Estrogen, neutrophils and oxidation.. Life Sci 2004 Oct 1;75(20):2425-38.
                pubmed: 15350818doi: 10.1016/j.lfs.2004.04.035google scholar: lookup
              6. Billinghurst RC, Brama PA, van Weeren PR, Knowlton MS, McIlwraith CW. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals.. Am J Vet Res 2004 Feb;65(2):143-50.
                pubmed: 14974569doi: 10.2460/ajvr.2004.65.143google scholar: lookup
              7. Mershon JL, Baker RS, Clark KE. Estrogen increases iNOS expression in the ovine coronary artery.. Am J Physiol Heart Circ Physiol 2002 Sep;283(3):H1169-80.
                pubmed: 12181148doi: 10.1152/ajpheart.00397.2000google scholar: lookup
              8. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species.. J Biol Chem 2002 May 17;277(20):17415-27.
                pubmed: 11877405doi: 10.1074/jbc.M112400200google scholar: lookup
              9. Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, Zegels B, Reginster JY, Henrotin Y. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.. Osteoarthritis Cartilage 2005 Mar;13(3):258-65.
                pubmed: 15727893doi: 10.1016/j.joca.2004.12.002google scholar: lookup
              10. Arai K, Misumi K, Carter SD, Shinbara S, Fujiki M, Sakamoto H. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.. Equine Vet J 2005 Jan;37(1):31-6.
                pubmed: 15651731doi: 10.2746/0425164054406784google scholar: lookup
              11. Brama PA, TeKoppele JM, Beekman B, van El B, Barneveld A, van Weeren PR. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.. Ann Rheum Dis 2000 Feb;59(2):155-7.
                pubmed: 10666176doi: 10.1136/ard.59.2.155google scholar: lookup
              12. Frisbie DD, Ray CS, Ionescu M, Poole AR, Chapman PL, McIlwraith CW. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses.. Am J Vet Res 1999 Mar;60(3):306-9.
                pubmed: 10188811
              13. Jouglin M, Robert C, Valette JP, Gavard F, Quintin-Colonna F, Denoix JM. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.. Vet Res 2000 Sep-Oct;31(5):507-15.
                pubmed: 11050746doi: 10.1051/vetres:2000136google scholar: lookup
              14. Henrotin YE, Zheng SX, Deby GP, Labasse AH, Crielaard JM, Reginster JY. Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes.. J Rheumatol 1998 Aug;25(8):1595-601.
                pubmed: 9712106
              15. Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY. Type II collagen peptides for measuring cartilage degradation.. Biorheology 2004;41(3-4):543-7.
                pubmed: 15299285
              16. Kuwabara K, Jyoyama H, Fleisch JH, Hori Y. Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na.. Inflamm Res 2002 Nov;51(11):541-50.
                pubmed: 12540018doi: 10.1007/pl00012425google scholar: lookup
              17. Cho MM, Ziats NP, Pal D, Utian WH, Gorodeski GI. Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms.. Am J Physiol 1999 Feb;276(2):C337-49.
                pubmed: 9950761doi: 10.1152/ajpcell.1999.276.2.C337google scholar: lookup
              18. Baldus S, Eiserich JP, Brennan ML, Jackson RM, Alexander CB, Freeman BA. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases.. Free Radic Biol Med 2002 Oct 1;33(7):1010.
                pubmed: 12361810doi: 10.1016/s0891-5849(02)00993-0google scholar: lookup
              19. Burner U, Furtmuller PG, Kettle AJ, Koppenol WH, Obinger C. Mechanism of reaction of myeloperoxidase with nitrite.. J Biol Chem 2000 Jul 7;275(27):20597-601.
                pubmed: 10777476doi: 10.1074/jbc.M000181200google scholar: lookup
              20. Henrotin Y, Deby-Dupont G, Deby C, De Bruyn M, Lamy M, Franchimont P. Production of active oxygen species by isolated human chondrocytes.. Br J Rheumatol 1993 Jul;32(7):562-7.
                pubmed: 8393361doi: 10.1093/rheumatology/32.7.562google scholar: lookup
              21. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.. FEBS Lett 1994 Aug 15;350(1):9-12.
                pubmed: 8062931doi: 10.1016/0014-5793(94)00722-5google scholar: lookup
              22. Todhunter RJ, Fubini SL, Freeman KP, Lust G. Concentrations of keratan sulfate in plasma and synovial fluid from clinically normal horses and horses with joint disease.. J Am Vet Med Assoc 1997 Feb 1;210(3):369-74.
                pubmed: 9057920
              23. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW. Myeloperoxidase produces nitrating oxidants in vivo.. J Clin Invest 2002 May;109(10):1311-9.
                pubmed: 12021246doi: 10.1172/JCI15021google scholar: lookup
              24. Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage.. Osteoarthritis Cartilage 2003 Oct;11(10):747-55.
                pubmed: 13129694doi: 10.1016/s1063-4584(03)00150-xgoogle scholar: lookup
              25. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.. Clin Chem 1998 Nov;44(11):2281-9.
                pubmed: 9799755
              26. Brama PA, TeKoppele JM, Beekman B, van Weeren PR, Barneveld A. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis.. Ann Rheum Dis 1998 Nov;57(11):697-9.
                pubmed: 9924215doi: 10.1136/ard.57.11.697google scholar: lookup
              27. van der Vliet A, O'Neill CA, Halliwell B, Cross CE, Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite.. FEBS Lett 1994 Feb 14;339(1-2):89-92.
                pubmed: 8313984doi: 10.1016/0014-5793(94)80391-9google scholar: lookup
              28. Stichtenoth DO, Frölich JC. Nitric oxide and inflammatory joint diseases.. Br J Rheumatol 1998 Mar;37(3):246-57.
                pubmed: 9566663doi: 10.1093/rheumatology/37.3.246google scholar: lookup
              29. Dimock AN, Siciliano PD, McIlwraith CW. Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint.. Equine Vet J 2000 Sep;32(5):439-43.
                pubmed: 11037267doi: 10.2746/042516400777591129google scholar: lookup
              30. Liang M, Ekblad E, Lydrup ML, Nilsson BO. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.. Cell Tissue Res 2003 Jul;313(1):63-70.
                pubmed: 12827494doi: 10.1007/s00441-003-0731-3google scholar: lookup
              31. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite.. Methods Enzymol 1994;233:229-40.
                pubmed: 8015460doi: 10.1016/s0076-6879(94)33026-3google scholar: lookup

              Citations

              This article has been cited 2 times.
              1. Turlo AJ, Cywinska A, Frisbie DD. Revisiting predictive biomarkers of musculoskeletal injury in thoroughbred racehorses: longitudinal study in polish population.. BMC Vet Res 2019 Feb 26;15(1):66.
                doi: 10.1186/s12917-019-1799-7pubmed: 30808359google scholar: lookup
              2. Verwilghen DR, Martens A, Busschers E, Franck T, Deberg M, Henrotin Y, Vanderheyden L, Serteyn D. Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis.. Vet Res Commun 2011 Oct;35(7):401-8.
                doi: 10.1007/s11259-011-9487-5pubmed: 21681550google scholar: lookup
              Subscribe to our newsletter
              Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.